Sunrest Lifescience Limited Share Price & Stock Analysis

Sunrest Lifescience Limited (NSE: SUNREST) is an Ahmedabad, Gujarat-based company in the Pharmaceuticals industry. With a market capitalisation of ₹15 Cr, it ranks #4,574 by market cap among the 6,197 Indian listed companies on FinBizNet, and #59 of 63 in Pharmaceuticals. At ₹36.00 (as of 16 Nov 2026), the share price is 33.3% below its 52-week high of ₹54.00 and 21.8% above its 52-week low of ₹29.55. The share price is down 26.5% over one year and up 2.4% over three months.

Key Metrics

Current Price₹36.00
Market Cap₹15 Cr
NSE SymbolSUNREST
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio3.8
Return on Equity22.43%
Return on Assets8.68%
52-Week Range₹29.55 – ₹54.00
1-Year Price Change-26.5%
3-Month Price Change+2.4%
Beta (1Y)0.11
HeadquartersAhmedabad, Gujarat
Websitesunrestlifescience.com

Shareholding and Delivery

Promoters held 53.50% of Sunrest Lifescience Limited's shares as of Jun 2026, against 69.91% in Jun 2025 (−16.41 percentage points).

About Sunrest Lifescience Limited

Sunrest Lifescience Limited manufactures, sells, and markets healthcare products, medicines, and cosmetic products in India. It markets various drugs, including anti-bacterials, antibiotics, anti-amoeibics, anti- fungals, analgesic, neuropathy, anti-hypertension, anti-inflammatory, anti-ulcerants, anti-cold, anti-cough, anti-allergics, nutritionals, ayurvedic, and cosmetics in various forms, such as tablets, capsules, soft gels, syrup, dry-syrups, injections, cream-ointments, and powders. The company sells its products through a network of distributors and retailers. Sunrest Lifescience Limited was incorporated in 2017 and is based in Ahmedabad, India.

Products and Services

1. Trading of Goods of Pharmaceuticals-This segment offers pharmaceutical products on wholesale and retail basis. 2. NA-NA 3. NA-NA 4. NA-NA

Sunrest Lifescience Limited vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Sunrest Lifescience Limited₹15 Cr3.822.43%—-26.5%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Sunrest Lifescience Limited?

Sunrest Lifescience Limited is trading at ₹36.00, with a market capitalisation of ₹15 Cr.

Which sector does Sunrest Lifescience Limited belong to?

Sunrest Lifescience Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Sunrest Lifescience Limited?

Sunrest Lifescience Limited has a P/E of 3.8 and a return on equity of 22.43%.

What is the stock symbol of Sunrest Lifescience Limited?

Sunrest Lifescience Limited is listed on the NSE under the symbol SUNREST.

How has Sunrest Lifescience Limited's share price moved over the past year?

Sunrest Lifescience Limited's share price is down 26.5% over one year and up 2.4% over three months. Its 52-week range is ₹29.55 to ₹54.00.

What is the promoter holding in Sunrest Lifescience Limited?

Promoters held 53.50% of Sunrest Lifescience Limited's shares as of Jun 2026, against 69.91% in Jun 2025 (−16.41 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.